In a significant leap for medical diagnostics, scientists in Australia have developed a cutting-edge artificial intelligence (AI) screening tool that provides pathologists with what is being described as "super vision." The tool, known as STimage, allows medical professionals to detect hidden cancer markers in routine tissue samples that would otherwise remain invisible to the human eye.
Developed by researchers at the QIMR (Queensland Institute of Medical Research) Berghofer Medical Research Institute, STimage utilizes spatial biology analysis. According to a recent statement from the institute, the machine learning tool can accurately predict breast, skin, and kidney cancers, as well as liver immune diseases. Beyond mere detection, the tool is also capable of assessing prognosis and evaluating how a patient might respond to specific treatments.
The findings, published in Nature Communications, highlight that STimage is not only reliable and low-cost but also generates results rapidly, making them easy for pathologists to interpret. This breakthrough is poised to usher in a new era of digital pathology and precision medicine, potentially enabling faster diagnoses and more personalized treatment plans. Furthermore, it could significantly improve access to specialist care for patients in remote areas.
Associate Professor Quan Nguyen, who led the development of the tool, likened the capability to a superhero's power. "It's like giving pathologists the super resolution vision of Superman or Superwoman to scan millions of invisible biomarkers in a tiny tissue sample to find the two or three that are showing signs of cancer," Nguyen explained.
Crucially, the researchers emphasize that STimage is designed to assist rather than replace human experts. By mathematically computing the level of certainty regarding a result, the tool provides essential data on cell types and genetic activity that are beyond human visual perception. The research team hopes that STimage will be integrated into standard clinical practice within the next two years, marking a transformative shift in how cancer is detected and treated globally.
Reference(s):
Study: AI tool gives pathologists 'super vision' to detect cancers
cgtn.com
